{"schema":"hottub-news/prospects/v1","item":{"id":"n_ve2diimos5lef3ylvnbq","title":"Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1","title_en":null,"url":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html","outlet":"redaccionmedica.com","published":"2026-11-10T11:00:00Z","sponsored":false,"page":"https://hottub.news/articles/n_ve2diimos5lef3ylvnbq"},"prospects":[{"name":"Julia Roiz","kind":"person","role":"reporter","company":"redaccionmedica.com","website":"https://redaccionmedica.com/","source":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html","note":"Wrote: Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1","reason":"Reporter at redaccionmedica.com; wrote “Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1” on 2026-11-10","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=Julia%20Roiz&company=redaccionmedica.com&website=https%3A%2F%2Fredaccionmedica.com%2F&source=https%3A%2F%2Fwww.redaccionmedica.com%2Fempresas%2Findustria-farmaceutica%2F20261110%2Festados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1%2F364651_0.html&note=Wrote%3A%20Estados%20Unidos%20exige%20reforzar%20las%20advertencias%20sobre%20los%20riesgos%20oculares%20asociados%20a%20los%20f%C3%A1rmacos%20GLP-1","propose":{"name":"Julia Roiz","kind":"person","reason":"Reporter at redaccionmedica.com; wrote “Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1” on 2026-11-10","requestId":"news:n_ve2diimos5lef3ylvnbq:Reporter:f9941176:502c466b","company":"redaccionmedica.com","website":"https://redaccionmedica.com/","sourceUrl":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html"}},{"name":"redaccionmedica.com","kind":"organization","role":"outlet","website":"https://redaccionmedica.com/","source":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html","note":"Published: Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1 (2026-11-10)","reason":"Published “Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1” on 2026-11-10","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=redaccionmedica.com&kind=organization&website=https%3A%2F%2Fredaccionmedica.com%2F&source=https%3A%2F%2Fwww.redaccionmedica.com%2Fempresas%2Findustria-farmaceutica%2F20261110%2Festados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1%2F364651_0.html&note=Published%3A%20Estados%20Unidos%20exige%20reforzar%20las%20advertencias%20sobre%20los%20riesgos%20oculares%20asociados%20a%20los%20f%C3%A1rmacos%20GLP-1%20%282026-11-10%29","propose":{"name":"redaccionmedica.com","kind":"organization","reason":"Published “Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1” on 2026-11-10","requestId":"news:n_ve2diimos5lef3ylvnbq:Outlet:3ae129db:9a899369","website":"https://redaccionmedica.com/","sourceUrl":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html"}}],"someone_else":{"source":"https://www.redaccionmedica.com/empresas/industria-farmaceutica/20261110/estados-unidos-exige-reforzar-las-advertencias-sobre-los-riesgos-oculares-asociados-farmacos-glp-1/364651_0.html","note":"In the news: Estados Unidos exige reforzar las advertencias sobre los riesgos oculares asociados a los fármacos GLP-1 (redaccionmedica.com, 2026-11-10)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}